Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroma Security Regulatory News (CSSG)

Share Price Information for Croma Security (CSSG)

Share Price is delayed by 15 minutes
Get Live Data
67.50    0.00 (0.00%)
Bid:
65.00
Ask:
70.00
Spread: 5.00 (7.692%)
Market Cap: £9.29m
CSSG Live PriceLast checked at - London Stock Exchange

Intraday Croma Security Share Chart

Contract Win

12 Nov 2008 07:00

RNS Number : 9509H
Croma Group PLC
12 November 2008
 



12 November 2008

CROMA GROUP PLC ('CROMA' OR 'THE GROUP')

Contract Win

The Board of Croma, the AIM listed security, homeland defence and avionics software specialistis pleased to announce that its wholly owned subsidiary, Vigilant Security Services ("Vigilant"), has won a 3 year contract to provide security services to Shasun Pharma Solutions ("Shasun"), the vertically integrated chemical partner for the pharmaceutical industry. The annual value of this contract is £600,000

Sebastian Morley, CEO, commented: "We are delighted with this large and prestigious contract win. The Vigilant team is consistently winning tenders in this competitive market and this marks a welcome diversification from our traditional defence related customers. We are finding that clients are demanding total value and service. Our uncompromising level of customer service and the ex HM Forces pragmatism we apply to security operations is proving very potent."

Enquiries:

Croma Group plc

Sebastian Morley, CEO  0776006909

Seymour Pierce Limited

Jeremy Garrett-Cox / Mark Percy 020 7107 8000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTDGMMMVMGGRZM
Date   Source Headline
3rd Jul 20237:00 amRNSCompletion of the Disposal & Total Voting Rights
30th Jun 20239:32 amRNSResult of General Meeting
6th Jun 20237:00 amRNSProposed Disposal of Vigilant for £6.5 million
28th Apr 20237:00 amRNSDirectorate Change
4th Apr 20237:00 amRNSDirectorate Change
14th Mar 20237:00 amRNSHalf-year Report
20th Jan 20237:00 amRNSDirectorate Change
20th Dec 20227:00 amRNSAcquisition of Safecell Security Group
6th Dec 20223:51 pmRNSResult of AGM
6th Dec 20227:00 amRNSAGM Statement, Potential Divestment, Board Changes
11th Nov 20227:00 amRNSFinal Results
27th Oct 20227:00 amRNSPublication of 2022 Final Results
15th Sep 20227:00 amRNSContract Wins & Trading Update
6th Jul 20227:00 amRNSAcquisition
31st Mar 20225:08 pmRNSDirector/PDMR Shareholding
29th Mar 20222:50 pmRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSHalf-year Report
24th Jan 20227:00 amRNSStrategic Partnership
26th Nov 202112:03 pmRNSGrant of Options, PDMR dealing
24th Nov 20211:36 pmRNSResult of AGM
18th Nov 20217:00 amRNSAcquisition
8th Nov 202112:28 pmRNSHolding(s) in Company
28th Oct 20212:38 pmRNSHolding(s) in Company
21st Oct 20217:00 amRNSFinal Results
6th Oct 202110:54 amRNSHolding(s) in Company
4th Oct 20217:00 amRNSTrading Statement and Strategic Partnership
2nd Jul 20217:44 amRNSHolding(s) in Company
28th Jun 20217:00 amRNSTrading Statement
24th Mar 20217:00 amRNSDirector/PDMR Shareholding
12th Mar 202110:07 amRNSHolding(s) in Company
1st Mar 20217:00 amRNSHalf-year Report
18th Jan 20217:00 amRNSHolding(s) in Company
25th Nov 20201:52 pmRNSResult of AGM
21st Oct 20207:00 amRNSFinal Results
13th Aug 202011:00 amRNSDividend Reinstated and Contract Win
2nd Jul 20207:00 amRNSDirector/PDMR Shareholding
1st Jul 20207:00 amRNSDirector/PDMR Shareholding
15th Jun 20207:00 amRNSContract Renewal and Uplift
8th Jun 20207:00 amRNSTrading Update
4th Jun 20204:40 pmRNSSecond Price Monitoring Extn
4th Jun 20204:35 pmRNSPrice Monitoring Extension
19th Mar 20203:01 pmRNSCancellation of Dividend
2nd Mar 20207:00 amRNSHalf-year Report
4th Feb 20208:12 amRNSHolding(s) in Company
24th Jan 202012:00 pmRNSHolding(s) in Company
27th Nov 20191:32 pmRNSResult of AGM
21st Oct 20197:00 amRNSFinal Results
29th Mar 20196:00 pmRNSHolding(s) in Company
18th Mar 201912:58 pmRNSDirector/PDMR Shareholding
26th Feb 20194:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.